Plasma levels of soluble glycoprotein VI (sGPVI) are associated with ischemic stroke

Platelets

Volumn 24, Issue 7, 2013, Pages 560-565

  Wurster, Thomas ^a   Poetz, Oliver ^b   Stellos, Konstantinos ^a   Kremmer, Elisabeth ^c   Melms, Arthur ^a   Schuster, Andreas ^d   Nagel, Eike ^d   Joos, Thomas ^b   Gawaz, Meinrad ^a   Bigalke, Boris ^a,d  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Ischemic stroke; Platelets; Soluble glycoprotein VI; TIA

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCOPROTEIN VI; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SOLUBLE GLYCOPROTEIN VI; UNCLASSIFIED DRUG;

AGED; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; FEMALE; FLUORESCENCE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; THROMBOCYTE MEMBRANE; TRANSIENT ISCHEMIC ATTACK;

AGED; FEMALE; HUMANS; MALE; PLATELET MEMBRANE GLYCOPROTEINS; STROKE;

EID: 84884802249     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2012.746455     Document Type: Article

References (42)

1. Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002;8:1227-1234
2. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet 2006;367:1747-1757
3. Nieswandt B, Watson SP. Platelet-collagen interaction: Is GPVI the central receptor? Blood 2003;102:449-461
4. Al-Tamimi M, Mu FT, Moroi M, Gardiner EE, Berndt MC, Andrews RK. Measuring soluble platelet glycoprotein VI in human plasma by ELISA. Platelets 2009;20:143-149
5. Bigalke B, Stellos K, Geisler T, Kremmer E, Seizer P, May AE, Lindemann S, Melms A, Luft A, Gawaz M. Expression of platelet glycoprotein VI is associated with transient ischemic attack and stroke. Eur J Neurol 2010;17:111-117
6. Bigalke B, Geisler T, Stellos K, Langer H, Daub K, Kremmer E, Seizer P, May AE, Lindemann S, Gawaz M. Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome. Am Heart J 2008;156:193-200
7. Anand N, Stead LG. Neuron-specific enolase as a marker for acute ischemic stroke: A systematic review. Cerebrovasc Dis 2005;20:213-219
8. Bertsch T, Casarin W, Kretschmar M, et al. Protein S-100B: A serum marker for ischemic and infectious injury of cerebral tissue. Clin Chem Lab Med 2001;39:319-323
9. Unden J, Strandberg K, Malm J, et al. Explorative investigation of biomarkers of brain damage and coagulation system activation in clinical stroke differentiation. J Neurol 2009;256:72-77
10. Doehner W, von Haehling S, Suhr J, et al. Elevated plasma levels of neuropeptide proenkephalin a predict mortality and functional outcome in ischemic stroke. J Am Coll Cardiol 2012;60:346-354
11. Montaner J, Perea-Gainza M, Delgado P, et al. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke 2008;39:2280-2287
12. Laskowitz DT, Kasner SE, Saver J, Remmel KS, Jauch EC. Clinical usefulness of a biomarker-based diagnostic test for acute stroke: The Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study. Stroke 2009;40:77-85
13. Bigalke B, Potz O, Kremmer E, et al. Sandwich immunoassay for soluble glycoprotein VI in patients with symptomatic coronary artery disease. Clin Chem 2011;57:898-904
14. Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: A statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: Co-sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Circulation 2006;113:e409-e449
15. Massberg S, Konrad I, Bultmann A, et al. Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo. FASEB J 2004;18:397-399
16. Carson RT, Vignali DA. Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. J Immunol Methods 1999;227:41-52
17. Bigalke B, Lindemann S, Ehlers R, et al. Expression of platelet collagen receptor glycoprotein VI is associated with acute coronary syndrome. Eur Heart J 2006;27:2165-2169
18. Cabeza N, Li Z, Schulz C, et al. Surface expression of collagen receptor Fc receptor-gamma/glycoprotein VI is enhanced on platelets in type 2 diabetes and mediates release of CD40 ligand and activation of endothelial cells. Diabetes 2004;53: 2117-2121
19. Varga-Szabo D, Pleines I, Nieswandt B. Cell adhesion mechanisms in platelets. Arterioscler Thromb Vasc Biol 2008;28:403-412
20. Bigalke B, Elvers M, Schonberger T, Gawaz M. Platelet and soluble glycoprotein VI-novel applications in diagnosis and therapy. Curr Drug Targets 2011;12:1821-1830
21. Bergmeier W, Rabie T, Strehl A, et al. GPVI down-regulation in murine platelets through metalloproteinase-dependent shedding. Thromb Haemost 2004;91:951-958
22. Stephens G, Yan Y, Jandrot-Perrus M, Villeval JL, Clemetson KJ, Phillips DR. Platelet activation induces metalloproteinase-dependent GP VI cleavage to down-regulate platelet reactivity to collagen. Blood 2005;105:186-191
23. Bender M, Hofmann S, Stegner D, et al. Differentially regulated GPVI ectodomain shedding by multiple platelet-expressed proteinases. Blood 2010;116:3347-3355
24. Heemskerk JW, Kuijpers MJ, Munnix IC, Siljander PR. Platelet collagen receptors and coagulation. A characteristic platelet response as possible target for antithrombotic treatment. Trends Cardiovasc Med 2005;15:86-92
25. Bultmann A, Herdeg C, Li Z, et al. Local delivery of soluble platelet collagen receptor glycoprotein VI inhibits thrombus formation in vivo. Thromb Haemost 2006;95:763-766
26. Bultmann A, Li Z, Wagner S, et al. Impact of glycoprotein VI and platelet adhesion on atherosclerosis-A possible role of fibronectin. J Mol Cell Cardiol 2010;49:532-542
27. Bigalke B, Stellos K, Weig HJ, et al. Regulation of platelet glycoprotein VI (GPVI) surface expression and of soluble GPVI in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS). Basic Res Cardiol 2009;104:352-357
28. Adams Jr. HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41
29. Al-Tamimi M, Tan CW, Qiao J, et al. Pathologic shear triggers shedding of vascular receptors: A novel mechanism for downregulation of platelet glycoprotein VI in stenosed coronary vessels. Blood 2012;119:4311-4320
30. Al-Tamimi M, Grigoriadis G, Tran H, et al. Coagulation-induced shedding of platelet glycoprotein VI mediated by factor Xa. Blood 2011;117:3912-3920
31. Gardiner EE, Karunakaran D, Arthur JF, et al. Dual ITAMmediated proteolytic pathways for irreversible inactivation of platelet receptors: De-ITAM-izing FcgammaRIIa. Blood 2008;111:165-174
32. Gardiner EE, Karunakaran D, Shen Y, Arthur JF, Andrews RK, Berndt MC. Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases. J Thromb Haemost 2007;5:1530-1537
33. Gardiner EE, Arthur JF, Kahn ML, Berndt MC, Andrews RK. Regulation of platelet membrane levels of glycoprotein VI by a platelet-derived metalloproteinase. Blood 2004;104:3611-3617
34. Al-Tamimi M, Gardiner EE, Thom JY, et al. Soluble glycoprotein VI is raised in the plasma of patients with acute ischemic stroke. Stroke 2011;42:498-500
35. Ungerer M, Rosport K, Bultmann A, et al. Novel antiplatelet drug revacept (Dimeric Glycoprotein VI-Fc) specifically and efficiently inhibited collagen-induced platelet aggregation without affecting general hemostasis in humans. Circulation 2011;123:1891-1899
36. Gruner S, Prostredna M, Aktas B, et al. Anti-glycoprotein VI treatment severely compromises hemostasis in mice with reduced alpha2beta1 levels or concomitant aspirin therapy. Circulation 2004;110:2946-2951
37. Hamm CW, Braunwald E. A classification of unstable angina revisited. Circulation 2000;102:118-122
38. Hamm CW, Goldmann BU, Heeschen C, Kreymann G, Berger J, Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997;337:1648-1653
39. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: Pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004;363:768-774
40. Alexandrov AV, Molina CA, Grotta JC, et al. Ultrasoundenhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004;351:2170-2178
41. van der Worp HB, van Gijn J. Clinical practice. Acute ischemic stroke. N Engl J Med 2007;357:572-579
42. Wurster T, Stellos K, Geisler T, et al. Expression of stromal-cellderived factor-1 (SDF-1): A predictor of ischaemic stroke? Eur J Neurol 2012;19:395-401